Literature DB >> 19680677

Antifibrotic effects of tocotrienols on human Tenon's fibroblasts.

Christoph Tappeiner1, Alexander Meyenberg, David Goldblum, Daniel Mojon, Jean-Marc Zingg, Kalanithi Nesaretnam, Monika Kilchenmann, Beatrice E Frueh.   

Abstract

PURPOSE: To compare the antifibrotic effect of vitamin E isoforms alpha-, gamma-, and delta-tocotrienol on human Tenon's fibroblasts (hTf) to the antimetabolite mitomycin C.
METHODS: Antifibrotic effects of alpha- (40, 60, 80, 100, and 120 microM), gamma- (10, 20, 30, and 40 microM) and delta-tocotrienol (10, 20, 30, and 40 microM) on hTf cultures were evaluated by performing proliferation, migration and collagen synthesis assays. Whereas for vitamin E the exposure time was set to 7 days to mimic subconjunctival application, cultures were exposed only 5 min to mitomycin C 100 microg/ml to mimic intraoperative administration. Cell morphology (phase contrast microscopy) as an assessment for cytotoxicity and cell density by measuring DNA content in a fluorometric assay to determine proliferation inhibition was performed on day 0, 4, and 7. Migration ability and collagen synthesis of fibroblasts were measured.
RESULTS: All tested tocotrienol isoforms were able to significantly inhibit hTf proliferation in a dose-dependent manner (maximal inhibitory effect without relevant morphological changes at day 4 for alpha-tocotrienol 80 microM with 36.7% and at day 7 for alpha-tocotrienol 80 microM with 42.6% compared to control). Degenerative cell changes were observed in cultures with concentrations above 80 microM for alpha- and above 30 microM for gamma- and delta-tocotrienol. The highest collagen synthesis inhibition has been found with 80 microM alpha-tocotrienol (62.4%) and no significant inhibition for mitomycin C (2.5%). Migration ability was significantly reduced in cultures exposed to 80 microM alpha- and 30 microM gamma-tocotrienol (inhibition of 82.2% and 79.5%, respectively, compared to control) and also after mitomycin C treatment (60.0%). Complete growth inhibition without significant degenerative cell changes could only be achieved with mitomycin C.
CONCLUSION: In vitro, all tested tocotrienol isoforms were able to inhibit proliferation, migration and collagen synthesis of human Tenon's fibroblasts and therefore may have the potential as an anti-scarring agent in filtrating glaucoma surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680677     DOI: 10.1007/s00417-009-1168-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  33 in total

Review 1.  Encapsulated filtering bleb. A selective review--new deductions.

Authors:  A Ophir
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

2.  Hypotony maculopathy following trabeculectomy with mitomycin C.

Authors:  H D Jampel; L R Pasquale; C Dibernardo
Journal:  Arch Ophthalmol       Date:  1992-08

3.  Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts.

Authors:  J G Crowston; A N Akbar; P H Constable; N L Occleston; J T Daniels; P T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-02       Impact factor: 4.799

Review 4.  Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells.

Authors:  Paul W Sylvester; Sumit J Shah
Journal:  Front Biosci       Date:  2005-01-01

5.  Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells.

Authors:  B S McIntyre; K P Briski; A Gapor; P W Sylvester
Journal:  Proc Soc Exp Biol Med       Date:  2000-09

6.  Mitomycin as adjunct chemotherapy with trabeculectomy.

Authors:  S S Palmer
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

7.  Five-year results of trabeculectomy with mitomycin C.

Authors:  Henny J M Beckers; Katja C Kinders; Carroll A B Webers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-01-25       Impact factor: 3.117

8.  Extraocular application of mitomycin C in a rabbit model: cytotoxic effects on the ciliary body and epithelium.

Authors:  H Mietz; K Addicks; M Diestelhorst; G K Krieglstein
Journal:  Ophthalmic Surg       Date:  1994-04

9.  Vitamin E isoforms alpha-tocotrienol and gamma-tocopherol prevent cerebral infarction in mice.

Authors:  Kenichi Mishima; Takamitsu Tanaka; Fengling Pu; Nobuaki Egashira; Katsunori Iwasaki; Ryoji Hidaka; Kazuhisa Matsunaga; Jiro Takata; Yoshiharu Karube; Michihiro Fujiwara
Journal:  Neurosci Lett       Date:  2003-01-30       Impact factor: 3.046

10.  d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties.

Authors:  A Tasinato; D Boscoboinik; G M Bartoli; P Maroni; A Azzi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more
  3 in total

1.  Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology.

Authors:  Alessandra Bolotta; Antonella Pini; Provvidenza M Abruzzo; Alessandro Ghezzo; Alessandra Modesti; Tania Gamberi; Carla Ferreri; Francesca Bugamelli; Filippo Fortuna; Silvia Vertuani; Stefano Manfredini; Cinzia Zucchini; Marina Marini
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-03

2.  Dietary vitamin E affects small intestinal histomorphology, digestive enzyme activity, and the expression of nutrient transporters by inhibiting proliferation of intestinal epithelial cells within jejunum in weaned piglets1.

Authors:  Cancan Chen; Zhaobin Wang; Jianzhong Li; Yali Li; Pengfei Huang; Xueqin Ding; Jia Yin; Shanping He; Huansheng Yang; Yulong Yin
Journal:  J Anim Sci       Date:  2019-03-01       Impact factor: 3.159

Review 3.  The Involvement of the Oxidative Stress Status in Cancer Pathology: A Double View on the Role of the Antioxidants.

Authors:  Kamal Fatima Zahra; Radu Lefter; Ahmad Ali; Ech-Chahad Abdellah; Constantin Trus; Alin Ciobica; Daniel Timofte
Journal:  Oxid Med Cell Longev       Date:  2021-08-05       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.